We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.48%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.21B
AUM Growth
+$330M
Cap. Flow
+$275M
Cap. Flow %
22.73%
Top 10 Hldgs %
36.41%
Holding
4,516
New
1,790
Increased
1,264
Reduced
722
Closed
680

Sector Composition

Rank Sector Weight
1 Financials 6.31%
2 Technology 5.59%
3 Industrials 5.06%
4 Consumer Discretionary 3.68%
5 Healthcare 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEB icon
3326
Seaboard Corp
SEB
$4.21B
$5K ﹤0.01%
+1
New +$4.27K
SENEA icon
3327
Seneca Foods Class A
SENEA
$1.18B
$5K ﹤0.01%
152
+36
+31% +$1.07K
SNY icon
3328
Sanofi
SNY
$102B
$5K ﹤0.01%
+102
New +$4.94K
USFD icon
3329
US Foods
USFD
$21.8B
$5K ﹤0.01%
+204
New +$5.59K
VHI icon
3330
Valhi
VHI
$388M
$5K ﹤0.01%
+183
New +$5.88K
VRRM icon
3331
Verra Mobility
VRRM
$848M
$5K ﹤0.01%
+476
New +$4.76K
VTIP icon
3332
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$5K ﹤0.01%
99
-1
-1% -$49
WF icon
3333
Woori Financial
WF
$17B
$5K ﹤0.01%
+100
New +$4.88K
WU icon
3334
Western Union
WU
$2.28B
$5K ﹤0.01%
+283
New +$5.39K
XPRO icon
3335
Expro Ltd
XPRO
$1.88B
$5K ﹤0.01%
+106
New +$4.75K
PENG
3336
Penguin Solutions Inc
PENG
$2.96B
$5K ﹤0.01%
388
+382
+6,367% +$3.65K
ABLG
3337
Abacus FCF International Leaders ETF
ABLG
$16.5M
$5K ﹤0.01%
+200
New +$5.16K
PHLT
3338
DELISTED
Performant Healthcare Inc
PHLT
$5K ﹤0.01%
2,756
+30
+1% +$57
NAGE
3339
Niagen Bioscience
NAGE
$276M
$5K ﹤0.01%
1,159
+487
+72% +$1.78K
LUMO
3340
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$5K ﹤0.01%
51
-321
-86% -$24.6K
NEPT
3341
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$5K ﹤0.01%
3
+1
+50% +$1.2K
PATI
3342
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$5K ﹤0.01%
234
-374
-62% -$7.13K
AENZ
3343
DELISTED
Aenza S.A.A.
AENZ
$5K ﹤0.01%
+330
New +$3.58K
PLXP
3344
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$5K ﹤0.01%
746
-5
-0.7% -$32
SRNE
3345
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$5K ﹤0.01%
2,872
-4,724
-62% -$8.67K
ATNX
3346
DELISTED
Athenex, Inc. Common Stock
ATNX
$5K ﹤0.01%
15
-147
-91% -$49.8K
CEA
3347
DELISTED
China Eastern Airlines
CEA
$5K ﹤0.01%
+200
New +$5.53K
RDS.B
3348
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$5K ﹤0.01%
79
-1,642
-95% -$94.2K
CLGX
3349
DELISTED
Corelogic, Inc.
CLGX
$5K ﹤0.01%
+105
New +$4.77K
GNC
3350
DELISTED
GNC Holdings, Inc.
GNC
$5K ﹤0.01%
604
+307
+103% +$2.76K

Similar funds

Tower Research Capital (TRC)'s Q3 2017 Portfolio in Review

As of Q3 2017, Tower Research Capital (TRC) held 4,516 positions worth $1.21B, up 37% from $881M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $275M of net new capital in Q3 2017, opening 1,790 new positions and adding to 1,264 existing holdings. Its largest new stake was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.

By sector, the portfolio is most concentrated in Financials at 6.3% of assets, up from 2.1% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $60M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2017 buy was iShares Morningstar Mid-Cap ETF: 196,556 shares worth $8.59M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $135M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $60M.
  • Tower Research Capital (TRC) fully exited State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2017, selling an estimated $17.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $1.21B portfolio in Q3 2017.
  • Tower Research Capital (TRC) opened 1,790 new positions and closed 680 in Q3 2017.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.21B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.